Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software
NCT ID: NCT00956800
Last Updated: 2011-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2009-09-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes
NCT02896010
Remote Monitoring in Diabetes Disease Management
NCT00675311
Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management
NCT06848361
The Diabetes TeleCare Study
NCT00288132
Developing a mHealth Simulation Platform for Youth
NCT05953532
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There will be 50 patients in each group, matched for age and sex distribution, educational level, computer literacy, and type of diabetes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
telemedicine/study group
Accu-Chek 360 software
Study group which will receive 3 routine office visits in the same time, and have two visits conducted by computer interaction, using the Accu-Chek 360 software.
control group
Normal care
Control group will receive 5 routine office visits in one year
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Accu-Chek 360 software
Study group which will receive 3 routine office visits in the same time, and have two visits conducted by computer interaction, using the Accu-Chek 360 software.
Normal care
Control group will receive 5 routine office visits in one year
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 19-65 years of age
* Type 1 and 2 diabetes
* Computer literate
* Independent care of diabetes
* Insulin pump allowed (Spirit pump only)
* Females on birth control
* Can demonstrate competency in the use of the Accuchek Aviva meter, reliability in doing regular home blood sugar determinations
Exclusion Criteria
* Severe loss of vision (diabetic retinopathy)
* Severe diabetic neuropathy
* Known or suspected diabetic gastroparesis
* Patients with heart disease
* Patients with liver disease
* Drug or substantial alcohol use
* Use of pharmacological doses of glucocorticoids or other medications that affect blood sugar and blood pressure
* Females that are pregnant or are capable of becoming pregnant
* Insulin pump use other than Accucheck Spirit pump
19 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Columbus Research Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Columbus Research Foundation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven B Leichter, M.D.
Role: PRINCIPAL_INVESTIGATOR
Endocrine Consultants
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Columbus Research Foundation
Columbus, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Roche 360
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.